Influence of Inositol on the reproductive system of infertile patients, quality of gametes and embryos (a review)

Nazarenko T.A.; Isakova K.M.

doi:https://doi.org/10.17116/repro20182404133

Nazarenko T.A.

Kafedra akusherstva, ginekologii, perinatologii i reproduktologii fakul'teta poslediplomnogo professional'nogo obucheniia vracheĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova;
Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova

Isakova K.M.

Moscow Research Institute of Obstetrics and Gynecology, Moscow, Russia, 101000

Influence of Inositol on the reproductive system of infertile patients, quality of gametes and embryos (a review)

Authors:

Nazarenko T.A., Isakova K.M.

More about the authors

Journal: Russian Journal of Human Reproduction. 2018;24(4): 33‑36

DOI: 10.17116/repro20182404133

Read: 29771 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Nazarenko TA, Isakova KM. Influence of Inositol on the reproductive system of infertile patients, quality of gametes and embryos (a review). Russian Journal of Human Reproduction. 2018;24(4):33‑36. (In Russ.)
https://doi.org/10.17116/repro20182404133

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Features of the course of induced pregnancy during the transfer of a thawed embryo in women with polycystic ovary syndrome. Russian Journal of Human Reproduction. 2025;(1):54-62

Nutrient status of follicular fluid and blood serum in women with infertility as a marker of embryo quality. Pilot study. Russian Journal of Human Reproduction. 2025;(2):17-27

Age-related peculiarities of blood parameters in women and their impact on the outcome of in vitro fertilization programs. Russian Journal of Human Reproduction. 2025;(2):28-36

To the question of human oocytes dysmorphism and its influence on the parameters of early embryogenesis. Russian Journal of Human Reproduction. 2025;(3):48-54

The dependence of the ploidic status of embryos on the state of the spindle of oocyte division, assessed using polarization microscopy in IVF programs in women with ovarian endometriosis. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):44-49

The possibilities of predicting and reducing the risk of breast cancer in women against the background of the use of assisted reproductive technologies. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):59-64

Medical and social characteristics of maternal deaths after extracorporeal fertilization. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):5-14

Primary ovarian insufficiency: opportunities and prospects for the realization of reproductive function. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):42-47

The role of pelvic inflammatory diseases in reproductive function disorders in women. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):48-54

Characteristics of factors contributing to disorders of reproductive function in patients with adenomyosis. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):68-74

Abstract:

This literature review describes the possibility of using myoinositol for endocrine-metabolic symptoms treatment in patients with PCOS. The action mioinositol as a posible insulin sensitizer, which can be used as a safe and effective treatment option for patients with PKJ syndrome by restoring their metabolic profile and subsequent induction of ovulation in infertile patients.

Keywords:

mio-inositol

inositol

ART

IVF

infertility treatment

polycystic ovarian syndrome( PCOS)

Authors:

Nazarenko T.A.

Isakova K.M.

Moscow Research Institute of Obstetrics and Gynecology, Moscow, Russia, 101000

Close metadata

References:

Ben-Nagi J, Panay N. Premature ovarian insufficiency: how to improve reproductive outcome? Climacteric: the Journal of the International Menopause Society. 2014;17(3):242-246. https://doi.org/10.3109/13697137.2013.860115
Vol’ff M fon, Shtute P. Ginekologicheskaya endokrinologiya i reproduktivnaya meditsina. Per. s nem. pod obshch. red. Andreevoi EN. M.: MEDprecs-inform; 2017. (In Russ.)
Kissin DM, Kulkarni AD, Kushnir VA, Jamieson DJ; National ART Surveillance System Group. Number of embryos transferred after in vitro fertilization and good perinatal outcome. Obstetrics and Gynecology. 2014;123(2 Pt 1):239-247. https://doi.org/10.1097/aog.0000000000000106
Beck-Fruchter R, Weiss A, Lavee M, Geslevich Y, Shalev E. Empty follicle syndrome: successful treatment in a recurrent case and review of the literature. Human Reproduction. 2012;27(6):1357-1367. https://doi.org/10.1093/humrep/des037
Halloran BP, DeLuca HF. Effect of vitamin D deficiency on fertility and reproductive ability in the female rat. The Journal of Nutrition. 1980;110(8):1573-1580. https://doi.org/10.1093/jn/110.8.1573
Holick MF. Vitamin D: extraskeletal health. Rheumatic Diseases Clinics of North America. 2012;38(1):141-160. https://doi.org/10.1016/j.rdc.2012.03.013
Condorelli RA, La Vignera S, Di Bari F, Unfer V, Calogero AE. Effects of myoinositol on sperm mitochondrial function in-vitro. European Review for Medical and Pharmacological Sciences. 2011;15(2):129-134.
Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecological Endocrinology. 2008;24(3):139-144. https://doi.org/10.1080/09513590801893232
Clements RS, Darnell B. Myo-inositol content of common foods: development of a high-myo-inositol diet. The American Journal of Clinical Nutrition. 1980;33(9):1954-1967. https://doi.org/10.1093/ajcn/33.9.1954
Baillargeon J-P, Nestler JE, Ostlund RE, Apridonidze T, Diamanti-Kandarakis E. Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. Human Reproduction. 2008;23(6):1439-1446. https://doi.org/10.1093/humrep/den097\
Croze ML, Soulage CO. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie. 2013;95(10):1811-1827. https://doi.org/10.1016/j.biochi.2013.05.011
Morgante G, Orvieto R, Di Sabatino A, Musacchio MC, De Leo V. The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen. Fertility and Sterility. 2011;95(8):2642-2644. https://doi.org/10.1016/j.fertnstert.2011.01.035
Costantino D, Minozzi G, Minozzi E, Guaraldi C. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. European Review for Medical and Pharmacological Sciences. 2009;13(2):105-110.
Gerli S, Papaleo E, Ferrari A, Di Renzo GC. Randomized, double blind placebo-controlled trial: effects of Myo-inositol on ovarian function and metabolic factors in women with PCOS. European Review for Medical and Pharmacological Sciences. 2007;11(5):347-354.
Unfer V, Carlomagno G, Dante G, Facchinetti F. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecological Endocrinology. 2012;28(7):509-515. https://doi.org/10.3109/09513590.2011.650660
Raffone E, Rizzo P, Benedetto V. Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. Gynecological Endocrinology. 2010;26(4):275-280. https://doi.org/10.3109/09513590903366996
Kamenov Z, Kolarov G, Gateva A, Carlomagno G, Genazzani AD. Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecological Endocrinology. 2015;31(2):131-135. https://doi.org/10.3109/09513590.2014.964640
Genazzani D, Prati A, Santagni S, Ricchieri F, Chierchia E, Rattighieri E, Campedelli A, Simoncini T, Artini PG. Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients. Gynecological Endocrinology. 2012;28(12):969-973. https://doi.org/10.3109/09513590.2012.685205
Facchinetti F, Bizzarri M, Benvenga S, D’Anna R, Lanzone A, Soulage C, Di Renzo GC, Hod M, Cavalli P, Chiu TT, Kamenov ZA, Bevilacqua A, Carlomagno G, Gerli S, Oliva MM, Devroey P. Results from the International Consensus Conference on myo-inositol and d-chiro-inositol in obstetrics and gynecology: the link between metabolic syndrome and PCOS. European Journal of Obstetrics Gynecology and Reproductive Biology. 2015;195:72-76. https://doi.org/10.1016/j.ejogrb.2015.09.024
Sun T-H, Heimark DB, Nguygen T, Nadler JL, Larner J. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. Biochemical and Biophysical Research Communications. 2002;293(3):1092-1098. https://doi.org/10.1016/s0006-291x(02)00313-3
Papaleo E, Unfer V, Baillargeon JP, Fusi F, Occhi F, De Santis L. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertility and Sterility. 2009;91(5):1750-1754.
Condorelli RA, La Vignera S, Bellanca S, Vicari E, Calogero AE. Myoinositol: does it improve sperm mitochondrial function and sperm motility? Urology. 2012;79(6):1290-1295. https://doi.org/10.1016/j.urology.2012.03.005
Rizzo P, Raffone E, Benedetto V: Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial. European Review for Medical and Pharmacological Sciences. 2010;14:555-561.